Philips | PHIA - Des Atouts





Des Atouts Changement Date
ABB USD 44.63B 256M 2026-03
Abbott USD 110.43B 23.72B 2026-03
Aena EUR 19.19B 1B 2026-03
Alcon AG USD 31.62B 64M 2026-03
ASM International NV EUR 5.83B 492.2M 2026-03
ASML Holding 48.06B 2.51B 2026-03
AstraZeneca USD 114.02B 59M 2026-03
Bayer EUR 107.94B 3.4B 2026-03
Boston Scientific USD 44.35B 678M 2026-03
Demant DKK 39.07B 6.43B 2025-12
EDAP TMS EUR 61.46M 6.88M 2025-09
Edwards Lifesciences USD 13.32B 376M 2026-03
Essilor EUR 63.9B 1.97B 2025-12
Fresenius EUR 41.4B 1.07B 2025-12
Fresenius Medical Care EUR 31.47B 465.26M 2026-03
Geberit CHF 3.86B 252.6M 2025-12
Getinge SEK 63.92B 4.3B 2024-12
GN Store Nord DKK 28.56B 671M 2026-03
GRIFOLS EUR 20.08B 366M 2026-03
HeidelbergCement EUR 36.14B 1.47B 2025-12
Intuitive Surgical USD 20.11B 347.7M 2026-03
Koninklijke Philips EUR 31.65B 742.15M 2025-12
Legrand EUR 18.19B 599.1M 2026-03
Lonza CHF 18.97B 164M 2025-12
Medtronic USD 91.48B 139M 2025-12
Merck EUR 53.07B 1.54B 2026-03
Philips EUR 27.27B 322M 2026-03
Sanofi EUR 128.02B 1.22B 2026-03
SAP EUR 73.46B 3.1B 2026-03
Schneider Electric EUR 62.5B 538M 2025-12
Smith & Nephew USD 10.69B 150M 2025-12
Trinity Biotech USD 103.71M 4.08M 2025-09